Description

This Ministerial Order (MO) will give Health Canada an additional 15 days to review all clinical trial applications and amendments submitted under Division 5 of the Food and Drug Regulations.

Resources

Name	Format	Description	Link
Order to extend review period for clinical trial applications and amendments: Notice	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/covid-19-extension-notice.html
Order to extend review period for clinical trial applications and amendments: Notice	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/essais-cliniques/covid-19-avis-prolongations.html

Tags

Topics

Categories